Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online June 1, 2006
Stem Cells Vol. 24 No. 9 September 2006, pp. 2034 -2044
doi:10.1634/stemcells.2005-0554; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2005-0554v1
24/9/2034    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gazda, H. T.
Right arrow Articles by Beggs, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gazda, H. T.
Right arrow Articles by Beggs, A. H.

STEM CELL GENETICS AND GENOMICS

Defective Ribosomal Protein Gene Expression Alters Transcription, Translation, Apoptosis, and Oncogenic Pathways in Diamond-Blackfan Anemia

Hanna T. Gazdaa,b,c, Alvin T. Khoa,d,e, Despina Sanoudoub,c,f, Jan M. Zauchag, Isaac S. Kohanec,d,e, Colin A. Sieffa,c,h, Alan H. Beggsb,c

aDepartment of Pediatric Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA;
bGenomics Program and Division of Genetics,
dChildren’s Hospital Informatics Program, and
hDepartment of Hematology, Children’s Hospital Boston, Boston, Massachusetts, USA;
cHarvard Medical School, Boston, Massachusetts, USA;
eDivision of Health Sciences and Technology, Harvard University-Massachusetts Institute of Technology, Boston, Massachusetts, USA;
fFoundation for Biomedical Research, Academy of Athens, Athens, Greece;
gDepartment of Hematology/Oncology, University Medical School of Gdansk, Gdansk, Poland

Key Words. Diamond-Blackfan anemia • Bone marrow failure • Global gene expression • Ribosomal protein genes • Apoptosis • Cancer

Correspondence: Hanna Gazda, M.D., Children’s Hospital Boston, Genomics Program and Division of Genetics, 300 Longwood Avenue, Boston, Massachusetts 02115, USA. Telephone: 617-919-4587; Fax: 617-730-0253; e-mail: hanna.gazda{at}childrens.harvard.edu

Received November 9, 2005; accepted for publication May 23, 2006.
First published online in STEM CELLS EXPRESS   June 1, 2006.



Diamond-Blackfan anemia (DBA) is a broad developmental disease characterized by anemia, bone marrow (BM) erythroblastopenia, and an increased incidence of malignancy. Mutations in ribosomal protein gene S19 (RPS19) are found in ~25% of DBA patients; however, the role of RPS19 in the pathogenesis of DBA remains unknown. Using global gene expression analysis, we compared highly purified multipotential, erythroid, and myeloid BM progenitors from RPS19 mutated and control individuals. We found several ribosomal protein genes downregulated in all DBA progenitors. Apoptosis genes, such as TNFRSF10B and FAS, transcriptional control genes, including the erythropoietic transcription factor MYB (encoding c-myb), and translational genes were greatly dysregulated, mostly in diseased erythroid cells. Cancer-related genes, including RAS family oncogenes and tumor suppressor genes, were significantly dysregulated in all diseased progenitors. In addition, our results provide evidence that RPS19 mutations lead to codownregulation of multiple ribosomal protein genes, as well as downregulation of genes involved in translation in DBA cells. In conclusion, the altered expression of cancer-related genes suggests a molecular basis for malignancy in DBA. Downregulation of c-myb expression, which causes complete failure of fetal liver erythropoiesis in knockout mice, suggests a link between RPS19 mutations and reduced erythropoiesis in DBA.




This article has been cited by other articles:


Home page
Stem CellsHome page
K. Miyake, T. Utsugisawa, J. Flygare, T. Kiefer, I. Hamaguchi, J. Richter, and S. Karlsson
Ribosomal Protein S19 Deficiency Leads to Reduced Proliferation and Increased Apoptosis but Does Not Affect Terminal Erythroid Differentiation in a Cell Line Model of Diamond-Blackfan Anemia
Stem Cells, February 1, 2008; 26(2): 323 - 329.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
W. Goessling, T. E. North, and L. I. Zon
New Waves of Discovery: Modeling Cancer in Zebrafish
J. Clin. Oncol., June 10, 2007; 25(17): 2473 - 2479.
[Full Text] [PDF]


Home page
BloodHome page
J. Flygare and S. Karlsson
Diamond-Blackfan anemia: erythropoiesis lost in translation
Blood, April 15, 2007; 109(8): 3152 - 3154.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Choesmel, D. Bacqueville, J. Rouquette, J. Noaillac-Depeyre, S. Fribourg, A. Cretien, T. Leblanc, G. Tchernia, L. Da Costa, and P.-E. Gleizes
Impaired ribosome biogenesis in Diamond-Blackfan anemia
Blood, February 1, 2007; 109(3): 1275 - 1283.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
Email Content Delivery
Copyright © 2006 by AlphaMed Press.